191 related articles for article (PubMed ID: 16504926)
1. The pharmacokinetics and acute renal effects of oral microemulsion ciclosporin A in normal pigs.
Cibulskyte D; Pedersen M; Hjelm-Poulsen J; Hansen HE; Madsen M; Mortensen J
Int Immunopharmacol; 2006 Apr; 6(4):627-34. PubMed ID: 16504926
[TBL] [Abstract][Full Text] [Related]
2. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G
Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic characterization of a pig model of ciclosporin A nephrotoxicity following intravenous administration.
Cibulskyte D; Pedersen M; Jakobsen P; Hansen HE; Mortensen J
Pharmacol Res; 2007 Oct; 56(4):311-7. PubMed ID: 17870611
[TBL] [Abstract][Full Text] [Related]
4. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
[TBL] [Abstract][Full Text] [Related]
5. Chronic cyclosporine nephrotoxicity: a pig model.
Cibulskyte D; Kaalund H; Pedersen M; Hørlyck A; Marcussen N; Hansen HE; Madsen M; Mortensen J
Transplant Proc; 2005 Oct; 37(8):3298-301. PubMed ID: 16298579
[TBL] [Abstract][Full Text] [Related]
6. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
7. Telmisartan attenuates chronic ciclosporin A nephrotoxicity in a pig model.
Cibulskyte D; Pedersen M; Hørlyck A; Marcussen N; Hansen HE; Frøkiaer J; Madsen M; Mortensen J
Nephrol Dial Transplant; 2007 Feb; 22(2):369-75. PubMed ID: 17107964
[TBL] [Abstract][Full Text] [Related]
8. Effects of spironolactone in an experimental model of chronic cyclosporine nephrotoxicity.
Macunluoglu B; Arikan H; Atakan A; Tuglular S; Ulfer G; Cakalagaoglu F; Ozener C; Akoglu E
Transplant Proc; 2008; 40(1):273-8. PubMed ID: 18261605
[TBL] [Abstract][Full Text] [Related]
9. Oral cyclosporine A in neonatal swines for transplantation studies.
Pan H; Gazarian A; Buff S; Solla F; Gagnieu MC; Leveneur O; Watrelot-Virieux D; Morisset S; Sobh M; Michallet MC; Roger T; Dubernard JM; Michallet M
Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):19-25. PubMed ID: 25358107
[TBL] [Abstract][Full Text] [Related]
10. Relationship between area under the concentration versus time curve of cyclosporin A, creatinine clearance, hematocrit value, and other clinical factors in Japanese renal transplant patients.
Shibata N; Hoshino N; Minouchi T; Yamaji A; Park K; Tomoyoshi T; Abe H; Kodama M
Int J Clin Pharmacol Ther; 1998 Apr; 36(4):202-9. PubMed ID: 9587046
[TBL] [Abstract][Full Text] [Related]
11. Three-years experience with Neoral C2 monitoring adjusted to a target range of 500-600 ng/ml in long-term renal transplant recipients receiving dual immunosuppressive therapy.
Carstens J
Scand J Urol Nephrol; 2008; 42(3):286-92. PubMed ID: 18432535
[TBL] [Abstract][Full Text] [Related]
12. Renal outcome after ciclosporin-induced nephrotoxicity.
Tostivint I; du Montcel ST; Jaudon MC; Mallet A; Le Hoang P; Bodaghi B; Deray G; Bagnis CI
Nephrol Dial Transplant; 2007 Mar; 22(3):880-5. PubMed ID: 17127700
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients.
Dotti G; Gaspari F; Caruso R; Perico N; Remuzzi G; Barbui T; Rambaldi A
Haematologica; 2001 Mar; 86(3):311-5. PubMed ID: 11255279
[TBL] [Abstract][Full Text] [Related]
14. Effects of lactational cyclosporine A use on rat pups.
Türkmen MA; Kavukçu S; Sarioglu S; Soylu A; Akhunlar H; Yilmaz O; Güven H
Pediatr Transplant; 2006 Jun; 10(4):454-60. PubMed ID: 16712603
[TBL] [Abstract][Full Text] [Related]
15. Kidney volume increases during long-term ciclosporin a treatment.
Cibulskyte D; Engberg A; Pedersen M; Marcussen N; Hansen HE; Madsen M; Mortensen J
Transplant Proc; 2006 Oct; 38(8):2714-8. PubMed ID: 17098048
[TBL] [Abstract][Full Text] [Related]
16. Dual response of animals with chronic cyclosporine nephrotoxicity to an acute ischemic injury.
Campanholle G; Galvão-Pereira M; Cenedeze MA; de Paula A Teixeira V; dos Reis MA; Camara NO; Pacheco-Silva A
Transplant Proc; 2006 Dec; 38(10):3341-3. PubMed ID: 17175267
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic.
Brunet M; Crespo M; Millán O; Serón D; Torregrosa V; Jiménez O; Moreso F; Martorell J; Grinyo JM; Oppenheimer F
Transplant Proc; 2007 Sep; 39(7):2160-2. PubMed ID: 17889124
[TBL] [Abstract][Full Text] [Related]
18. Stable graft function after reduction of calcineurin inhibitor dosage in paediatric kidney transplant patients.
Plank C; Benz K; Amann K; Nüsken KD; Dittrich K; Rascher W; Sauerstein K; Stuppy A; Klare B; Dötsch J
Nephrol Dial Transplant; 2006 Oct; 21(10):2930-7. PubMed ID: 16837512
[TBL] [Abstract][Full Text] [Related]
19. Diltiazem modulates cyclosporin A induced renal hemodynamic effects but not its effect on plasma endothelin-1.
Asberg A; Christensen H; Hartmann A; Berg KJ
Clin Transplant; 1998 Oct; 12(5):363-70. PubMed ID: 9787942
[TBL] [Abstract][Full Text] [Related]
20. Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine A in renal transplantation.
Bunnag S; Vareesangthip K; Ong-ajyooth L
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S228-34. PubMed ID: 17044476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
